STUDY OBJECTIVES: To evaluate endothelium-dependent flow-mediated dilation (FMD) and endothelium-independent nitroglycerin (NTG)-induced dilation of the brachial artery with Doppler ultrasound in patients with obstructive sleep apnea (OSA) and impact of six months of continuous positive airway pressure (CPAP) treatment. DESIGN: A prospective, controlled, observational study. SETTING: Single-site, clinic-based. PATIENTS: Twenty-nine normotensive men with OSA (apnea-hypopnea index [AHI], mean +/- SD, 60.4 +/- 22.1-h), and 17 men without OSA (AHI 2.5 +/- 0.6-h). INTERVENTIONS: Six months of CPAP therapy in OSA patients. MEASUREMENTS AND RESULTS: FMD was lower in patients with OSA compared with in controls (7.19 +/- 1.78% vs 10.93 +/- 2.59%; P < 0.001) while NTG-induced vasodilation was similar in both groups (13.75 +/- 1.01% vs 14.25 +/- 1.83%; n.s.). An inverse relationship was found between FMD and AHI adjusted for age and body mass index (BMI) (beta = - 0.05, P < 0.001). Following 6 months of CPAP treatment in the OSA group, FMD was increased from 7.38 +/- 2.06% to 10.45 +/- 1.68; P = 0.001) in 20 patients compliant with the device whereas the corresponding values did not change in the non-user group (7.08 +/- 1.50% vs 7.26 +/- 1.01%). No significant changes were observed regarding the NTG-induced vasodilation after CPAP compared with the baseline values. CONCLUSIONS: Our results confirm the previous reports suggesting impaired endothelium-dependent FMD in OSA, and additionally document the sustained improvement in endothelial function after 6 months of CPAP treatment in complaint patients.
STUDY OBJECTIVES: To evaluate endothelium-dependent flow-mediated dilation (FMD) and endothelium-independent nitroglycerin (NTG)-induced dilation of the brachial artery with Doppler ultrasound in patients with obstructive sleep apnea (OSA) and impact of six months of continuous positive airway pressure (CPAP) treatment. DESIGN: A prospective, controlled, observational study. SETTING: Single-site, clinic-based. PATIENTS: Twenty-nine normotensive men with OSA (apnea-hypopnea index [AHI], mean +/- SD, 60.4 +/- 22.1-h), and 17 men without OSA (AHI 2.5 +/- 0.6-h). INTERVENTIONS: Six months of CPAP therapy in OSA patients. MEASUREMENTS AND RESULTS:FMD was lower in patients with OSA compared with in controls (7.19 +/- 1.78% vs 10.93 +/- 2.59%; P < 0.001) while NTG-induced vasodilation was similar in both groups (13.75 +/- 1.01% vs 14.25 +/- 1.83%; n.s.). An inverse relationship was found between FMD and AHI adjusted for age and body mass index (BMI) (beta = - 0.05, P < 0.001). Following 6 months of CPAP treatment in the OSA group, FMD was increased from 7.38 +/- 2.06% to 10.45 +/- 1.68; P = 0.001) in 20 patients compliant with the device whereas the corresponding values did not change in the non-user group (7.08 +/- 1.50% vs 7.26 +/- 1.01%). No significant changes were observed regarding the NTG-induced vasodilation after CPAP compared with the baseline values. CONCLUSIONS: Our results confirm the previous reports suggesting impaired endothelium-dependent FMD in OSA, and additionally document the sustained improvement in endothelial function after 6 months of CPAP treatment in complaint patients.
Authors: Daniel R Witte; Jan Westerink; Eelco J de Koning; Yolanda van der Graaf; Diederick E Grobbee; Michiel L Bots Journal: J Am Coll Cardiol Date: 2005-06-21 Impact factor: 24.094
Authors: P Clarkson; D S Celermajer; A E Donald; M Sampson; K E Sorensen; M Adams; D K Yue; D J Betteridge; J E Deanfield Journal: J Am Coll Cardiol Date: 1996-09 Impact factor: 24.094
Authors: M Hashimoto; M Akishita; M Eto; M Ishikawa; K Kozaki; K Toba; Y Sagara; Y Taketani; H Orimo; Y Ouchi Journal: Circulation Date: 1995-12-15 Impact factor: 29.690
Authors: L Sardo; P Palange; F Di Mario; B Barbano; A Gigante; M Mordenti; A Steffanina; M Bonini; A Amoroso; F Vaccaro; R Cianci Journal: Sleep Breath Date: 2015-04-01 Impact factor: 2.816
Authors: Fadi Seif; Sanjay R Patel; Harneet Walia; Michael Rueschman; Deepak L Bhatt; Daniel J Gottlieb; Eldrin F Lewis; Susheel P Patil; Naresh M Punjabi; Denise C Babineau; Susan Redline; Reena Mehra Journal: J Sleep Res Date: 2013-01-19 Impact factor: 3.981
Authors: Kanika Bagai; James A S Muldowney; Yanna Song; Lily Wang; Jayant Bagai; Kay J Artibee; Douglas E Vaughan; Beth A Malow Journal: Sleep Date: 2014-02-01 Impact factor: 5.849
Authors: Henry Blomster; Tomi Laitinen; Tiina Lyyra-Laitinen; Esko Vanninen; Helena Gylling; Markku Peltonen; Tarja Martikainen; Johanna Sahlman; Jouko Kokkarinen; Jukka Randell; Grigori Smirnov; Juha Seppä; Henri Tuomilehto Journal: Sleep Breath Date: 2013-06-04 Impact factor: 2.816
Authors: Francesca L Facco; David W Ouyang; Phyllis C Zee; Anna E Strohl; Anna B Gonzalez; Courtney Lim; William A Grobman Journal: Am J Obstet Gynecol Date: 2013-12-25 Impact factor: 8.661